A critical discovery in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant suppressor protein is frequently disabled in many forms of tumors, causing https://wildbookmarks.com/story22151829/vhh-fragments-restore-tumor-suppressor-p53-new-promising-hope-for-cancer-management